GHK-Cu

GHK-Cu 50mg is a research-grade copper-binding tripeptide complex developed for laboratory investigations involving extracellular matrix biology, copper transport mechanisms, peptide-mediated cellular signaling, tissue remodeling, molecular biochemistry, and regenerative biology. The peptide consists of the naturally occurring tripeptide Glycyl-L-Histidyl-L-Lysine (GHK) coordinated with a copper ion (Cu²⁺), forming a stable complex widely investigated for its biochemical properties and molecular interactions. Since its initial identification in human plasma, GHK-Cu has become one of the most extensively studied copper peptides within peptide biology and regenerative science.

One of the defining characteristics of GHK-Cu research is its relationship with copper homeostasis and copper-dependent biological systems. Researchers investigate how GHK-Cu facilitates copper transport, regulates metal ion availability, and participates in intracellular biochemical processes involving metalloproteins and enzyme activity. These investigations continue expanding scientific understanding of trace element biology without implying approved therapeutic outcomes.

Scientific investigations also focus extensively on extracellular matrix (ECM) biology. Laboratory studies evaluate GHK-Cu interactions with molecular systems associated with extracellular matrix organization, collagen-related pathways, elastin biology, glycosaminoglycan regulation, matrix remodeling, and coordinated cellular communication. Researchers continue investigating these mechanisms to better understand connective tissue biology within controlled laboratory environments.

Another major area of investigation involves cellular signaling and molecular communication. Researchers examine peptide-mediated signaling involving growth factor regulation, intracellular messenger systems, transcriptional activity, protein expression, and coordinated biochemical adaptation. These investigations contribute to expanding knowledge of peptide biology while maintaining an exclusive Research Use Only designation.

Current laboratory investigations further evaluate intracellular signaling involving TGF-β, MAPK/ERK, PI3K/Akt, NF-κB, matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), copper-dependent enzymes, and additional molecular pathways associated with extracellular matrix regulation and cellular remodeling. Researchers investigate these pathways to better understand peptide-mediated biochemical communication and tissue biology.

Comparative peptide research represents another major area of scientific interest. Researchers frequently compare GHK-Cu with BPC-157, TB-500, Glutathione, MOTS-c, and other investigational compounds to evaluate differences in molecular signaling, copper-binding characteristics, extracellular matrix interactions, biochemical stability, and laboratory applications. Comparative investigations continue expanding scientific understanding of peptide pharmacology and regenerative biology.

The 50mg presentation is particularly appropriate for institutional laboratory research, large-scale extracellular matrix investigations, extended peptide interaction studies, analytical validation, biomarker discovery, comparative peptide pharmacology, high-throughput biochemical screening, and collaborative scientific initiatives requiring larger quantities of research-grade investigational material. Although the presentation size differs from lower-strength offerings, the molecular identity, manufacturing process, analytical quality standards, and intended research applications remain consistent throughout the GHK-Cu product family.

Beyond extracellular matrix investigations, GHK-Cu serves as an important analytical reference material within peptide chemistry, analytical chemistry, molecular biology, metalloprotein research, biomaterials science, biomarker discovery, analytical method development, systems biology, and cellular physiology. Its reproducible analytical profile makes it valuable for laboratories investigating copper-peptide interactions and molecular signaling networks.

Each batch of GHK-Cu 50mg is manufactured according to research-grade production standards and undergoes comprehensive analytical verification before release. Quality assurance procedures include High-Performance Liquid Chromatography (HPLC) purity analysis, molecular identity confirmation, peptide sequence verification, copper complex validation, molecular weight characterization, and rigorous batch-specific quality control testing. These analytical measures support reproducibility, consistency, and confidence across independent laboratory investigations.

To preserve molecular integrity, GHK-Cu should be stored according to accepted laboratory recommendations for lyophilized peptides. Appropriate storage conditions, controlled handling practices, and adherence to established laboratory protocols help maintain peptide stability before analytical evaluation and experimental preparation.

Although GHK-Cu remains one of the most extensively investigated copper-binding peptides, ongoing scientific research continues exploring extracellular matrix biology, copper transport, cellular signaling, matrix remodeling, metalloprotein regulation, and comparative peptide biology. Consequently, GHK-Cu 50mg should be regarded exclusively as an investigational research peptide intended to support laboratory research and scientific discovery.

GHK-Cu 50mg is supplied exclusively for laboratory research and analytical applications. This product is intended for Research Use Only (RUO) and is not approved for human consumption, therapeutic use, veterinary applications, or diagnostic purposes.